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Abstract
Background: Laparoscopic cholecystectomy is now considered the first option for gallbladder
surgery. However, 20% to 30% of cholecystectomies are completed as open operations often on
elderly and fragile patients. The external validity of randomised trials comparing mini-laparotomy
cholecystectomy and laparoscopic cholecystectomy has not been studied. The aim of this study is
to analyse characteristics, procedures, and outcomes for all patients who underwent
cholecystectomy without being included in such a trial.
Methods: Characteristics (age, sex, co-morbidity, and ASA-score), operation time, hospital stay,
and mortality were compared for patients who underwent cholecystectomy outside and within a
randomised controlled trial comparing mini-laparotomy and laparoscopic cholecystectomy.
Results: During the inclusion period 1719 patients underwent cholecystectomy. 726 patients were
randomised and 724 of them completed the trial; 993 patients underwent cholecystectomy outside
the trial. The non-randomised patients were older – and had more complications from gallstone
disease, higher co-morbidity, and higher ASA – score when compared with trial patients. They
were also more likely to undergo acute surgery and they had a longer postoperative hospital stay,
with a median 3 versus 2 days (p < 0.001 for all comparisons). Standardised mortality ratio within
90 days of operation was 3.42 (mean) (95% CI 2.17 to 5.13) for non-randomised patients and 1.61
(mean) (95%CI 0.02 to 3.46) for trial patients. For non-randomised patients, operation time did not
differ significantly between mini-laparotomy and open cholecystectomy in multivariate analysis.
However, the operation for laparoscopic cholecystectomy lasted 20 minutes longer than open
cholecystectomy. Hospital stay was significantly shorter for both mini-laparotomy and laparoscopic
cholecystectomy compared to open cholecystectomy.
Conclusion:  Non-randomised patients were older and more sick than trial patients. The
assignment of healthier patients to trials comparing mini-laparotomy cholecystectomy and
laparoscopic cholecystectomy limits the external validity of conclusions reached in such trials.
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Background
External validity of conclusions reached in a randomised
trial depends upon the number and characteristics of eli-
gible patients not included in the trial (excluded by
patient or researcher) and number and characteristics of
patients who do not meet the eligibility criteria [1].
According to the CONSORT [2] recommendations, the
external validity of a study should be reported. However,
in surgical trials, there is often a lack of data concerning
the pre-randomisation collection of patients.
The laparoscopic technique has been adopted as the
method of choice for cholecystectomy, and epidemiolog-
ical studies indicate that 70% to 80% of all cholecystecto-
mies are now completed laparoscopically [3-5]. However,
in single-blind, randomised controlled trials the differ-
ence in convalescence between small-incision open sur-
gery (mini-laparotomy cholecystectomy) and
laparoscopic cholecystectomy is small and of short dura-
tion [6,7]. No previous study has reported data on non-
randomised patients. The present report describes charac-
teristics, operation time, postoperative hospital stay, and
postoperative mortality of all non-randomised cholecys-




Data for all patients over age 18 advised to undergo elec-
tive or acute cholecystectomy were prospectively recorded
at four non-university hospitals and one university centre.
Patients undergoing cholecystectomy as adjunct to other
major abdominal operations such as pancreatic resection,
hepatic resection and aneurysmectomy were excluded.
The protocol included information on previous and
present cholecystitis, pancreatitis, jaundice, and suspected
or proven malignancy; American Society of Anaesthesiol-
ogists' (ASA) score; co-morbidity (heart disease, lung dis-
ease, liver/renal disease, diabetes with insulin treatment,
steroid therapy); diagnostic investigations; and indication
for surgery (elective/acute).
Trial
Eligible patients were considered for inclusion in a ran-
domised controlled trial comparing minilaparotomy and
laparoscopic cholecystectomy. Patients were given verbal
and written information about the trial and asked if they
wished to participate. Exclusion criteria for the trial were:
age under 18 years, jaundice, obesity (body mass index
>45), pregnancy, cirrhosis of the liver, suspected or
proven malignancy, and previous upper gastrointestinal
surgery. Recruitment of patients, randomisation, blind-
ing, sample size calculation, control panel and rules for
stopping the trial, data collection, and processing have
been described in previous reports [7,8]. During the inclu-
sion period, 1705 cholecystectomy patients were identi-
fied. Scrutiny of medical records yielded another 14 non-
randomised patients. 726 patients were randomised, but
two randomised patients were withdrawn: one patient
unexpectedly had disseminated malignancy found at
laparoscopy and the other patient was randomised to
laparoscopic cholecystectomy but was operated with
minilaparotomy for unknown reasons. This change was
detected too late in data handling to allow collection of
necessary information. Analysis was otherwise performed
on an "intention-to-treat" basis for both randomised and
non-randomised patients. Thus, a converted laparoscopic
operation was classified as laparoscopic cholecystectomy
and mini-laparotomy cholecystectomy with extended
incision (beyond 8 cm) as mini-laparotomy cholecystec-
tomy. 277 patients were excluded from the trial according
to protocol (exclusion criteria), 472 patients were
excluded by surgeons in charge, and 244 patients, did not
want to participate in the trial. Thus, characteristics and
outcomes for 993 non-randomised patients and 724 ran-
domised patients could be compared. Approval of the
Ethics Committee was obtained.
Surgery
Laparoscopic cholecystectomy was performed according
to routines at the participating units. Mini-laparotomy
was defined as cholecystectomy performed through a
laparotomy incision less than 8 cm. Trainees were encour-
aged to participate in surgery under supervision, as is rou-
tine practice. Complications were classified according to
Clavien et al [9].
Statistics
Outcome of qualitative variables, for example acute chole-
cystitis (yes/no) or co-morbidity (no/at least one disease
or item) was compared using chi-square analysis. The dis-
tribution of quantitative variables (e.g. operating time,
hospital stay) was compared using the Kolmogorov-Smir-
nov non-parametric two-sample test. Mortality within 90
days and from 91 to 365 days of surgery was calculated as
the standardised mortality ratio (SMR) i. e. ratio between
the observed and expected number of deceased patients,
taking into account sex and age of individuals. Mortality
after cholecystectomy in a defined population is raised
above that of the standard population until 90 days after
operation [4] and therefore this postoperative period was
used for assessment of postoperative mortality.
Among non-randomised patients, operation time and
hospital stay for open cholecystectomy, mini-laparotomy
cholecystectomy, and laparoscopic cholecystectomy were
compared using multiple regression analysis with open
cholecystectomy as a reference. First, the influence of
acute cholecystitis, pancreatitis, jaundice, malignancy, co-
morbidity, ASA-score, common bile duct exploration,BMC Surgery 2006, 6:17 http://www.biomedcentral.com/1471-2482/6/17
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bilio-digestive shunt operation (choledocho-duodenos-
tomy), concomitant operation, and acute operation was
tested using univariate analyses. Adjustments were then
made for these variables in a multiple regression analysis.
Results
Non-randomised versus randomised patients
Table 1 shows the characteristics of trial patients and non-
randomised patients. The gender distribution did not dif-
fer between the two groups. Trial patients were younger
and less likely to have acute operations, complications of
gallstone disease, associated diseases, and ASA scores III
and IV. Malignancy was identified in 27 of 993 non-ran-
domised patients, 2.7%.
The procedures used for non-randomised patients are
shown in Table 2. 52.4% of these patients were treated
with conventional open cholecystectomy, 15.5% with
mini-laparotomy, and 32.1% with laparoscopic cholecys-
tectomy. The trial protocol did not exclude concomitant
operations, but these were more common among non-
randomised patients (6.9% vs 2.8%). Operation time, re-
operation rate, and re-admissions did not differ between
trial patients and non-randomised patients, whereas non-
randomised patients had a longer postoperative stay (p <
0.001) (Table 3). As shown in Table 4, the risk of death for
non-randomised patients significantly exceeded that of
the standard population within 90 days of surgery.
Operation time and postoperative hospital stay in non-
randomised patients
According to multiple regression analysis, operation time
for mini-laparotomy cholecystectomy and open cholecys-
tectomy in non-randomised patients did not differ signif-
icantly, whereas laparoscopic cholecystectomy took
significantly longer (20 minutes) than open cholecystec-
tomy (Table 5). Hospital stay was significantly shorter for
both mini-laparotomy cholecystectomy and laparoscopic
cholecystectomy compared to open cholecystectomy.
Discussion
The principal findings of present study are that non-ran-
domised patients were older and more sick than trial
patients and more likely to have an acute operation. Of all
non-randomised patients 67.9% were operated with open
methods, 52.4% with conventional open cholecystec-
tomy, and 15.5% with mini-laparotomy cholecystectomy.
In contrast to trial patients, non-randomised patients had
a threefold excess death rate compared to the background
population during the postoperative period. Multivariate
analyses demonstrated that operation time for non-ran-
domised patients did not differ between open cholecys-
tectomy and mini-laparotomy, whereas laparoscopic
cholecystectomy took 20 minutes longer. Postoperative
hospital stay was shorter for both mini-laparotomy chole-
cystectomy and laparoscopic cholecystectomy compared
to open cholecystectomy.
The strength of the study is the completeness of the data.
All cholecystectomies performed during the inclusion
period are taken into account. The weaknesses of the
study primarily relate to timing. Our study was conducted
at a time when laparoscopic cholecystectomy had been in
use for five years in Sweden and surgeons' experience with
mini-laparotomy was limited. Cholecystectomy was not
performed as day-case surgery at the time of the trial, but
day-cases have since been introduced both for laparo-
scopic cholecystectomy and mini-laparotomy at the hos-
pitals participating in the present trial.
Cholecystectomy in elderly and vulnerable patients, who
often have complications of gallstone disease, is associ-
ated with considerable mortality [5,10]. Therefore, it is an
expected observation that our non-randomised patients
had a postoperative mortality three times that of the
standard population. Whereas 32% of all cholecystecto-
mies performed from 1995 to 1999 in Sweden for acute or
chronic gallbladder disease were completed as open oper-
ations, the majority of patients over age 70 had an open
operation [5]. Under these circumstances, the high per-
centage of open cholecystectomy among our non-ran-
domised patients is not surprising. Nevertheless, the
number of conventional open cholecystectomy compared
to mini-laparotomy cholecystectomy is a matter of con-
cern, as randomised controlled trials [11-13] have con-
cluded that the surgical trauma is greater after
conventional open cholecystectomy than after mini-
laparotomy cholecystectomy.
Table 1: Characteristics of trial patients and non-randomised patients




Pancreatitis Jaundice Malignancy Associated
diseases
ASA III+IV
nn% M e a n S D n% n % n % n% n % n %n %
Trial patients 724 501 69.2 50.6 15.6 106 14.6 72 8.6 0 0 0 154 21.3 28 3.9
Non-randomised
patients
993 657 66.2 56.5 19.1 516 52.0 405 40.8 53 5.4 140 14.1 27 2.7 336 33.8 99 14.1
p = 0.18 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001BMC Surgery 2006, 6:17 http://www.biomedcentral.com/1471-2482/6/17
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Our multiple regression analyses indicated that mini-
laparotomy was a cost-effective alternative to laparoscopic
cholecystectomy among non-randomised patients. This
finding agrees with findings in single-blind randomised
controlled trials [8,14]. and observational studies [15,16]
demonstrating low health care costs for mini-laparotomy
cholecystectomy. The effectiveness of an operation can
only be assessed on an unselected set of patients and only
when surgery has been performed as part of the normal
hospital routine. Outcomes after mini-laparotomy chole-
cystectomy that are comparable to outcomes after laparo-
scopic cholecystectomy have been reported from units/
surgeons where mini-laparotomy is the standard proce-
dure [15-17] or regularly practised [18,19].
Conclusion
We found that non-randomised patients were more vul-
nerable than trial patients. Mini-laparotomy should
Table 5: Operation time and postoperative hospital stay for non-randomised patients according to multiple regression analysis
Operation time* min Postoperative hospital stay** Days
MC – OC -2.7 p = 0.50 -1.3 p = 0.004
LC – OC 20.2 p < 0.001 -1.2 p = 0.003
MC = minilaparotomy cholecystectomy, LC = laparoscopic cholecystectomy, and OC = conventional open cholecystectomy. Figures indicate 
adjusted differences between MC or LC and OC.
*Operation time adjusted for common bile duct exploration and concomitant operation.
**Postoperative hospital stay adjusted for pancreatitis, malignant disease, common bile duct exploration, biliodigestive shunt operation, co-
morbidity, ASA-score, concomitant operation, and acute operation.
Table 3: Operation time, postoperative stay, and re-operation of trial patients and non-randomised patients
N Operation time, min Postoperative stay, days Re-operation Re-admitted within 30 days
Mean SD Mean Median Percentiles N % N %
25% 75%
Trial patients 724 101 45 2.6 2 1 3 17 2.3 47 6.5
Non-randomised
patients
993 100 47 4.9 3 2 6 23 2.3 60 6.1
p = 0.67 P < 0.001 p = 0.92 p = 0.71
Table 2: Operations on trial patients and non-randomised patients
OC LC MC CBDE Shunt Concomitant operation
nN%n%n%n% n % N %
Trial patients 724 0 362 50.0 362 50.0 39 5.4 0 20 2.8
Non-randomised patients 993 520 52.4 319 32.1 154 15.5 201 20.2 15 1.5 69 6.9
p < 0.001 p < 0.001 P < 0.001
OC = conventional open cholecystectomy, LC = Laparoscopic cholecystectomy, MC = mini-laparotomy cholecystectomy, CBDE = common bile 
duct exploration, Shunt = choledochoduodenostomy, Concomitant operation = other operation performed in combination with cholecystectomy.
Table 4: Standardised mortality ratio (SMR), mean and (95% CI)
0 – 90 days 91 – 365 days
N Deaths SMR Deaths SMR
Trial patients 724 1 1.61 (0.02 – 3.46) 3 0.62 (0.13 – 1.78)
Non-randomised patients 993 23 3.42 (2.17 – 5.13) 26 1.27 (0.90–1.86)Publish with BioMed Central    and   every 
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replace conventional open cholecystectomy whenever
possible. The versatility of mini-laparotomy has impor-
tant implications for cost-effectiveness in gallbladder sur-
gery. Low external validity of conventional randomised
controlled trials as demonstrated in this report may to a
great extent be overcome by expertise based randomised
trials [20].
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